Matthew T David
Insider
First SEC filing: Jan. 17, 2024 · Latest: Jan. 17, 2024
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 10, 2025 | CRMD | F | 6,515 | $11.19 | $72,903 | 95,270 Direct | -6.40% | Disposed | -36.5% (price as of 2026-10-05) |
| Jan. 2, 2025 | CRMD | F | 8,648 | $8.22 | $71,087 | 101,786 Direct | -7.83% | Disposed | -13.5% (price as of 2026-10-05) |
| Jan. 2, 2025 | CRMD | A | 62,500 | · | · | 110,434 Direct | +130.39% | Acquired | (price as of 2026-10-05) |
| Jan. 12, 2024 | CRMD | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 12, 2024 | CRMD | F | 5,216 | $3.47 | $18,100 | 47,934 Direct | -9.81% | Disposed | 104.9% (price as of 2026-10-05) |
| Jan. 12, 2024 | CRMD | A | 50,000 | · | · | 53,150 Direct | +1587.30% | Acquired | (price as of 2026-10-05) |
| Jan. 14, 2023 | CRMD | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 18, 2022 | CRMD | A | None | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 6, 2021 | CRMD | P | 1,000 | $4.50 | $4,500 | 3,150 Direct | +46.51% | Acquired | 58.0% (price as of 2026-10-05) |
| Dec. 6, 2021 | CRMD | P | 1,000 | $4.50 | $4,500 | 3,150 Direct | +46.51% | Acquired | 58.0% (price as of 2026-10-05) |
| Nov. 17, 2021 | CRMD | P | 1,000 | $5.07 | $5,070 | 2,150 Direct | +86.96% | Acquired | 40.2% (price as of 2026-10-05) |
| Nov. 1, 2021 | CRMD | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 11, 2021 | CRMD | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 3, 2020 | CRMD | P | 1,150 | $4.07 | $4,680 | 1,150 Direct | · | Acquired | 74.7% (price as of 2026-10-05) |
| May 11, 2020 | CRMD | A | 125,000 | $4.08 | $510,000 | 125,000 Direct | · | Acquired | 74.3% (price as of 2026-10-05) |
| May 11, 2020 | CRMD | A | 125,000 | $5.63 | $703,750 | 125,000 Direct | · | Acquired | 26.3% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 12, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $3.47 | Jan. 11, 2034 | 100,000 | Acquired |
| Jan. 14, 2023 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $4.43 | Jan. 14, 2033 | 125,000 | Acquired |
| Feb. 18, 2022 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $4.03 | Feb. 18, 2032 | · | Acquired |
| Nov. 1, 2021 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $5.56 | Nov. 1, 2031 | 125,000 | Acquired |
| Jan. 11, 2021 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $8.32 | Jan. 11, 2031 | 80,000 | Acquired |
| May 11, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $4.08 | May 11, 2030 | 125,000 | Acquired |
| May 11, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $5.63 | May 11, 2030 | 125,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $351,923 | $75,900 | · | $951,895 | · | · | $43,584 | $1,423,302 |
| 2020 | $209,423 | · | · | $768,386 | $99,000 | · | $20,866 | $1,097,675 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.